Literature DB >> 649750

Determination of chlorthalidone in plasma, urine and red blood cells by gas chromatography with nitrogen detection.

H L Fleuren, J M Van Rossum.   

Abstract

A sensitive and selective gas chromatographic method is described for determining the diuretic and antihypertensive drug chlorthalidone in plasma, urine and erythrocytes. Use is made of an alkali flame ionization detector (nitrogen detector), and the chlorthalidone and internal standard are chromatographed as methyl derivatives. Down to 10 ng of drugs in the biological sample can be measured accurately, with a standard deviation of 5%. Because the concentration of chlorthalidone found in erythrocytes is 50-100 times higher than that in plasma, the influence of haemolysis on the plasma concentration has been investigated. In addition, a pharmacokinetic study with human volunteers revealed that the apparent concentration of the drug found in plasma can be much too low (by more than 50%), if the plasma is not separated from the erythrocytes immediately after venipuncture. Precautions to be observed to ensure correct handling of blood samples (so that results for plasma concentrations will be reliable) are stressed. The findings have application in kinetic studies on chlorthalidone.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 649750     DOI: 10.1016/s0021-9673(00)85332-7

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Nonlinear relationship between plasma and red blood cell pharmacokinetics of chlorthalidone in man.

Authors:  H L Fleuren; J M van Rossum
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

4.  Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension.

Authors:  J C Roos; P Boer; H A Koomans; G G Geyskes; E J Dorhout Mees
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.

Authors:  H L Fleuren; T A Thien; C P Verwey-van Wissen; J M van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.